摘要 |
The invention relates to guanidine compounds of general formula (I), corresponding enantiomeric, diastereomeric, and/or tautomeric forms thereof, and pharmaceutically acceptable salts thereof. The invention further relates to the use of guanidine compounds as binding partners for 5-HT5 receptors in order to treat diseases modulated by 5-HT5 receptor activity, especially treat neurodegenerative and neuropsychiatric disorders and the signs, symptoms, and malfunctions associated therewith. |
申请人 |
ABBOTT GMBH & CO. KG;NETZ, ASTRID;AMBERG, WILHELM;LANGE, UDO;OCHSE, MICHAEL;HUTCHINS, CHARLES, W.;GARCIA-LADONA, FRANCISCO-XAVIER;WERNET, WOLFGANG;MEZLER, MARIO;SAUER, DARYL;BURNS, DAVID;KLING, ANDREAS |
发明人 |
NETZ, ASTRID;AMBERG, WILHELM;LANGE, UDO;OCHSE, MICHAEL;HUTCHINS, CHARLES, W.;GARCIA-LADONA, FRANCISCO-XAVIER;WERNET, WOLFGANG;MEZLER, MARIO;SAUER, DARYL;BURNS, DAVID;KLING, ANDREAS |